Nathan C - Search Results

1

Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.

Wipperman MF, Bhattarai SK, Vorkas CK, Maringati VS, Taur Y, Mathurin L, McAulay K, Vilbrun SC, Francois D, Bean J, Walsh KF, Nathan C, Fitzgerald DW, Glickman MS, Bucci V. Wipperman MF, et al. Among authors: nathan c. Nat Commun. 2021 Feb 18;12(1):1141. doi: 10.1038/s41467-021-21475-y. Nat Commun. 2021. PMID: 33602926 Free PMC article.

2

Antibiotics at the crossroads.

Nathan C. Nathan C. Nature. 2004 Oct 21;431(7011):899-902. doi: 10.1038/431899a. Nature. 2004. PMID: 15496893 No abstract available.

3

A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.

Nathan C, Gold B, Lin G, Stegman M, de Carvalho LP, Vandal O, Venugopal A, Bryk R. Nathan C, et al. Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S25-33. doi: 10.1016/S1472-9792(08)70034-9. Tuberculosis (Edinb). 2008. PMID: 18762150 Review.

4

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

Shigyo K, Ocheretina O, Merveille YM, Johnson WD, Pape JW, Nathan CF, Fitzgerald DW. Shigyo K, et al. Antimicrob Agents Chemother. 2013 Jun;57(6):2834-7. doi: 10.1128/AAC.02542-12. Epub 2013 Mar 18. Antimicrob Agents Chemother. 2013. PMID: 23507275 Free PMC article.

5

Drug-resistant tuberculosis: a new shot on goal.

Nathan C. Nathan C. Nat Med. 2014 Feb;20(2):121-3. doi: 10.1038/nm.3470. Nat Med. 2014. PMID: 24504402 No abstract available.

6

Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.

Nandakumar M, Nathan C, Rhee KY. Nandakumar M, et al. Among authors: nathan c. Nat Commun. 2014 Jun 30;5:4306. doi: 10.1038/ncomms5306. Nat Commun. 2014. PMID: 24978671 Free article.

7

TB drug development: immunology at the table.

Nathan C, Barry CE 3rd. Nathan C, et al. Immunol Rev. 2015 Mar;264(1):308-18. doi: 10.1111/imr.12275. Immunol Rev. 2015. PMID: 25703568 Free PMC article. Review.

8

Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK.

Lupoli TJ, Fay A, Adura C, Glickman MS, Nathan CF. Lupoli TJ, et al. Among authors: nathan cf. Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7947-E7956. doi: 10.1073/pnas.1617644113. Epub 2016 Nov 21. Proc Natl Acad Sci U S A. 2016. PMID: 27872278 Free PMC article.

9

Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.

McAulay K, Saito K, Warrier T, Walsh KF, Mathurin LD, Royal-Mardi G, Lee MH, Ocheretina O, Pape JW, Fitzgerald DW, Nathan CF. McAulay K, et al. mBio. 2018 Nov 20;9(6):e02192-18. doi: 10.1128/mBio.02192-18. mBio. 2018. PMID: 30459198 Free PMC article.

10

Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis.

Walsh KF, McAulay K, Lee MH, Vilbrun SC, Mathurin L, Jean Francois D, Zimmerman M, Kaya F, Zhang N, Saito K, Ocheretina O, Savic R, Dartois V, Johnson WD, Pape JW, Nathan C, Fitzgerald DW. Walsh KF, et al. Among authors: nathan c. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e01956-19. doi: 10.1128/AAC.01956-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32071052 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

701 results

Search Page